Cervical cancer risk in HPV‐positive women after a negative FAM19A4/mir124‐2 methylation test: A post hoc analysis in the POBASCAM trial with 14 year follow‐up

DNA methylation analysis of cervical scrapes using FAM19A4 and mir124‐2 genes has shown a good clinical performance in detecting cervical cancer and advanced CIN lesions in need of treatment in HPV‐positive women. To date, longitudinal data on the cancer risk of methylation test‐negative women are l...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Cancer
Main Authors: De Strooper, Lise M.A., Berkhof, Johannes, Steenbergen, Renske D.M., Lissenberg‐Witte, Birgit I., Snijders, Peter J.F., Meijer, Chris J.L.M., Heideman, Daniëlle A.M.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2018
Assuntos:
Cancer Therapy and Prevention
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6099282/
https://ncbi.nlm.nih.gov/pubmed/29663363
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ijc.31539
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados